Synthesis of 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3- hydroxytetradecanyl]-alpha-D-glucopyranosyl dihydrogen phosphate and 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3- hydroxytetradecanyl]-4-O-phosphono-D-glucopyranose.
Shiozaki
M
M
New Lead Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.
Kobayashi
Y
Y
Ishida
N
N
Arai
M
M
Hiraoka
T
T
Nishijima
M
M
Kuge
S
S
Otsuka
T
T
Akamatsu
Y
Y
D000818:Animals; D002236:Carbohydrate Conformation; D016923:Cell Death / Q000187:drug effects; D002460:Cell Line; D004926:Escherichia coli; D006017:Glycolipids / Q000138:chemical synthesis* / Q000737:chemistry* / Q000494:pharmacology; D007202:Indicators and Reagents; D008264:Macrophages / Q000166:cytology / Q000187:drug effects; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D013329:Structure-Activity Relationship
D006017:Glycolipids; D007202:Indicators and Reagents; C074476:2-deoxy-2-(3-hydroxytetradecanamido)-3-O-(3-hydroxytetradecanyl)glucopyranosyl dihydrogen phosphate; C074478:2-deoxy-2-((3R)-3-hydroxy-tetradecanamido)-3-O-(3-hydroxytetradecanyl)-4-O-phosphonoglucopyranose; C044283:lipid X